Rodrigo Bazan

@fmb.unesp.br

Associate Professor
Unesp - Universidade Estadual Paulista



              

https://researchid.co/rodrigo.bazan

RESEARCH, TEACHING, or OTHER INTERESTS

Neurology (clinical), Neuroscience, Neurology, General Neuroscience

157

Scopus Publications

4555

Scholar Citations

30

Scholar h-index

74

Scholar i10-index

Scopus Publications

  • Prevalence of motoric cognitive risk syndrome among older adults in Brazil and evaluation of effect modification by race
    João Paulo Martins, Fernanda Bono Fukushima, Leandra Navarro Benatti, Rodrigo Bazan, Katherine Di Santi Correa da Silva, and Edison Iglesias de Oliveira Vidal

    SAGE Publications
    Background Motoric cognitive risk syndrome (MCRS) is a pre-dementia syndrome of growing interest, yet it remains understudied in Latin America with a significant lack of information on the interaction between its risk factors and race. Objective To estimate the prevalence of MCRS among older adults in Brazil, investigate its association with various clinical and sociodemographic variables, and explore the potential of effect modification by race. Methods This cross-sectional, population-based study was conducted among community-dwelling older adults in Brazil, with data collected between 2015 and 2016. The diagnosis of MCRS was established following the standard recommended by the original study that first described it. We used Poisson regression models to analyze the association between MCRS and a list of 21 variables identified from a systematic review. Results A total of 4677 participants aged 60 years and older were included. The prevalence of MCRS in the Brazilian population of older adults was 4.34% (95% CI: 3.20%–5.48%). Higher levels of education and physical activity showed protective associations with MCRS, while depression and stroke demonstrated risk associations. A significant cross-over interaction between race and depression regarding MCRS was observed, such that the association of depression with MCRS was approximately three times higher among White individuals than Black individuals. Conclusions Our results challenge previous estimates that Latin America is the region with the highest prevalence of MCRS among older adults and signal the need for further studies to better investigate the modification of effect of the association between depression and MCRS by race.

  • Long-term effect of non-invasive brain stimulation on hemispatial neglect, functional outcomes, and mortality after stroke: ELETRON trial extend
    Luana Aparecida Miranda, Fernanda Cristina Winckler, Taís Regina da Silva, Hélio Rubens de Carvalho Nunes, Gabriel Pinheiro Modolo, Natalia Cristina Ferreira, Diandra B. Favoretto, Luan Aguiar, Silméia Garcia Zanati Bazan, Taiza G.S. Edwards,et al.

    Elsevier BV

  • NIH stroke scale and unfavourable outcomes in acute ischaemic stroke: retrospective study
    Maiara Silva Tramonte, Ana Claudia Pires Carvalho, Ana Elisa Vayego Fornazari, Gustavo Di Lorenzo Villas Boas, Gabriel Pinheiro Modolo, Natalia Cristina Ferreira, Marcos Christiano Lange, Marcos Ferreira Minicucci, Rodrigo Bazan, and Laura Cardia Gomes Lopes

    BMJ
    ObjectivesTo evaluate the determining factors of severe functional impairment (SFI) outcome at discharge and in-hospital mortality in patients who had an acute ischaemic stroke and thus favouring early implementation of primary palliative care (PC).MethodsA retrospective descriptive study by the analysis of 515 patients who had an acute ischaemic stroke admitted at stroke unit, aged≥18 years, from January 2017 to December 2018. Previous clinical and functional status data, National Institute of Health Stroke Scale (NIHSS) on admission, and data related to the evolution during hospitalisation were evaluated, relating them to the SFI outcome at discharge and death. The significance level was set at 5%.ResultsOf 515 patients included, 15% (77) died, 23.3%(120) had an SFI outcome and 9.1% (47) were evaluated by the PC team. It was observed that NIHSS Score≥16 is responsible for a 15.5-fold increase in the occurrence of death outcome. The presence of atrial fibrillation was responsible for a 3.5-fold increase in the risk of this outcome.ConclusionNIHSS Score is an independent predictor of in-hospital death and SFI outcomes at discharge. Knowledge about the prognosis and risk of developing unfavourable outcomes is important for planning the care of patients affected by a potentially fatal and limiting acute vascular insult.

  • Influence of CReatine Supplementation on mUScle Mass and Strength After Stroke (ICaRUS Stroke Trial): A Randomized Controlled Trial
    Juli T. Souza, Marcos F. Minicucci, Natália C. Ferreira, Bertha F. Polegato, Marina P. Okoshi, Gabriel P. Modolo, Filipe W. Leal-Pereira, Bethan E. Phillips, Philip J. Atherton, Kenneth Smith,et al.

    MDPI AG
    Background/Objectives: The acute phase of stroke is marked by inflammation and mobility changes that can compromise nutritional status. This study was a randomized, double-blind, placebo-controlled trial evaluating the effectiveness of creatine supplementation for older people during seven days of hospitalization for stroke compared to usual care. Method: The primary outcome measures were changes in functional capacity, strength, muscle mass, and muscle degradation. The secondary outcomes were changes in serum biomarkers related to inflammation, fibrosis, anabolism, and muscle synthesis. In addition, a follow-up 90 days after the stroke verified functional capacity, strength, quality of life, and mortality. Following admission for an acute stroke, participants received either creatine (10 g) or a visually identical placebo (10 g) orally twice daily. Both groups received supplementation with protein to achieve the goal of 1.5 g of protein/kg of body weight/day and underwent daily mobility training during seven days of hospitalization. Results: Thirty older people were included in two similar groups concerning baseline attributes (15—treatment/15—placebo). Conclusions: Creatine supplementation did not influence functional capacity, strength, or muscle mass during the first 7 days or outcomes 90 days after stroke. There were no serious adverse events associated with creatine supplementation. However, it decreased progranulin levels, raising a new possibility of creatine action. This finding needs further exploration to understand the biological significance of creatine–progranulin interaction.

  • Effects of anodal transcranial direct current stimulation on intracranial compliance in the subacute phase of stroke
    Monalisa Resende Nascimento, Tiago Soares Bernardes, Kelly Cristina Sousa Santos, Gabrielly Fernanda Silva, Rodrigo Bazan, Luciane Aparecida Pascucci Sande de Souza, and Gustavo José Luvizutto

    Elsevier BV

  • Caregiver burden, hopelessness, and anxiety: Association between sociodemographic and clinical profiles of patients with stroke
    Luis Henrique Vallesquino Murayama, Pedro Tadao Hamamoto Filho, Fernanda Cristina Winckler, Havy Alexssander Abrami Meirelles, Natalie Carlos Ferreira Mello Sampaio, Bruno Zanluqui Moreira, Raul Pansardis Sampaio, Renan Macionil Cotrim, Silméia Garcia Zanati Bazan, Cristiane Lara Mendes Chiloff,et al.

    Elsevier BV

  • Custo Direto do Tratamento do Acidente Vascular Cerebral Isquêmico na Perspectiva de um Hospital Público Terciário (Direct Cost of Treating Ischemic Stroke From the Perspective of a Tertiary Public Hospital)
    Juliana Tereza Coneglian de Almeida, Rodrigo Bazan, Sarah Nascimento Silva, Lukas Fernando Silva, Juliana Machado Rugolo, Mônica Aparecida de Paula de Sordi, Carlos Clayton Macedo de Freitas, and Vania dos Santos Nunes-Nogueira

    Elsevier BV

  • Left Atrial Volume versus Coronary Artery Calcium Score in Patients on Peritoneal Dialysis: An Observational Study
    Fabrício Moreira Reis, Eduarda Baccarin Ferrari, Nayrana Soares do Carmo Reis, Fabiana Lourenço Costa, Paula Naomi Morimoto, Alejandra Del Carmen Villanueva Maurício, João Carlos Hueb, Rodrigo Bazan, Vanessa Burgugi Banin, Pasqual Barretti,et al.

    MDPI AG
    Background: The coronary artery calcium score and left atrial volume have been shown to predict the incidence of acute myocardial infarction and death from cardiovascular disease in patients undergoing peritoneal dialysis. However, the association between these factors has not been well-established. Methods: This cross-sectional, prospective, single-center study was conducted on patients undergoing outpatient peritoneal dialysis, who were followed up at a university hospital between March 2018 and August 2019. The coronary artery calcium score was calculated based on cardiovascular computed tomography findings. The score was “positive” when it was ≥100 Agatston and “negative” when it was <100 Agatston. The left atrial volume was obtained using the biplane disc method at the end of the left ventricular systole, and then it was indexed to the body surface. Results: Forty-four patients were evaluated. They had an age [mean (range)] of 56 (43–65) years and had been on dialysis therapy for 11.7 (6.8–25.4) months. Univariate analysis revealed a relationship between the coronary artery calcium score and left atrial volume index and the following variables: age, diabetes, overhydration, pulse wave velocity, E/A ratio, and left ventricular mass index. In multivariate logistic regression analysis, only the left atrial volume index was independently associated with a positive coronary artery calcium score. Conclusions: The left atrial volume index was associated with a positive coronary artery calcium score in patients on peritoneal dialysis, regardless of other factors. It may be a useful risk marker for coronary artery disease in this population.

  • Decompressive Craniectomy in Patients with Malignant Stroke with Additional Vascular Territory
    Raul Pansardis Sampaio, Marcelo Ortolani Fogaroli, Fabio Pires Botta, Gabriel Pinheiro Módolo, Gustavo José Luvizutto, Luiz Eduardo Betting, Marco Antônio Zanini, Rodrigo Bazan, and Pedro Tadao Hamamoto Filho

    Elsevier BV

  • Nonlinear EEG Analysis During Motor and Cognitive Tasks in Patients With Long COVID: A Dynamic Systems Approach
    Gislene Diniz Morais, Pablo Andrei Appelt, Eduardo de Moura Neto, Rodrigo Bazan, Ariana Moura Cabral, Adriano de Oliveira Andrade, Gustavo José Luvizutto, and Luciane Aparecida Pascucci Sande de Souza

    SAGE Publications
    Introduction. Nonlinear EEG provides information about dynamic properties of the brain. This study aimed to compare nonlinear EEG parameters estimated from patients with Long COVID in different cognitive and motor tasks. Materials and Methods. This 12-month prospective cohort study included 83 patients with Long COVID: 53 symptomatic and 30 asymptomatic. Brain electrical activity was evaluated by EEG in 4 situations: (1) at rest, (2) during the Trail Making Test Part A (TMT-A), (3) during the TMT Part B (TMT-B), and (4) during a coordination task: the Box and Blocks Test (BBT). Nonlinear EEG parameters were estimated in the time domain (activity and complexity). Assessments were made at 0 to 3, 3 to 6, and 6 to 12 months after inclusion. Results. There was a decrease in activity and complexity during the TMT-A and TMT-B, and an increase of these parameters during the BBT in both groups. There was an increase in activity at rest and during the TMT-A in the COVID-19 group at 0 to 3 months compared to the control, an increase in activity in the TMT-B in the COVID-19 group at 3 to 6 months compared to the control, and reduced activity and complexity at rest and during the TMT-A at 6 to 12 months compared to the control. Conclusion. The tasks followed a pattern of increased activity and complexity in cognitive tasks, which decreased during the coordination task. It was also observed that an increase in activity at rest and during cognitive tasks in the early stages, and reduced activity and complexity at rest and during cognitive tasks in the late phases of Long COVID.

  • Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
    Shelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, Juan F Arenillas, Zarina Assis, Peter Bailey, Philip A Barber, Rodrigo Bazan, Brian H Buck, Ken S Butcher,et al.

    Elsevier BV

  • Association of cardiovascular risk factors and myocardial hypertrophy in women with preeclampsia history
    Ricardo Mattos Ferreira, Fabiane Valentini Francisqueti Ferron, Vera Therezinha Medeiros Borges, José Carlos Peraçoli, Artur Junio Togneri Ferron, Meliza Goi Roscani, João Carlos Hueb, Rodrigo Bazan, Luis Cuadrado Martin, and Silméia Garcia Zanati Bazan

    Elsevier BV

  • Outcomes of Decompressive Surgery for Patients With Severe Cerebral Venous Thrombosis: DECOMPRESS2 Observational Study
    Sanjit Aaron, Jorge M. Ferreira, Jonathan M. Coutinho, Patrícia Canhão, Adriana B. Conforto, Antonio Arauz, Marta Carvalho, Jaime Masjuan, Vijay K. Sharma, Jukka Putaala,et al.

    Ovid Technologies (Wolters Kluwer Health)
    BACKGROUND: Decompressive neurosurgery is recommended for patients with cerebral venous thrombosis (CVT) who have large parenchymal lesions and impending brain herniation. This recommendation is based on limited evidence. We report long-term outcomes of patients with CVT treated by decompressive neurosurgery in an international cohort. METHODS: DECOMPRESS2 (Decompressive Surgery for Patients With Cerebral Venous Thrombosis, Part 2) was a prospective, international cohort study. Consecutive patients with CVT treated by decompressive neurosurgery were evaluated at admission, discharge, 6 months, and 12 months. The primary outcome was death or severe disability (modified Rankin Scale scores, 5–6) at 12 months. The secondary outcomes included patient and caregiver opinions on the benefits of surgery. The association between baseline variables before surgery and the primary outcome was assessed by multivariable logistic regression. RESULTS: A total of 118 patients (80 women; median age, 38 years) were included from 15 centers in 10 countries from December 2011 to December 2019. Surgery (115 craniectomies and 37 hematoma evacuations) was performed within a median of 1 day after diagnosis. At last assessment before surgery, 68 (57.6%) patients were comatose, fixed dilated pupils were found unilaterally in 27 (22.9%) and bilaterally in 9 (7.6%). Twelve-month follow-up data were available for 113 (95.8%) patients. Forty-six (39%) patients were dead or severely disabled (modified Rankin Scale scores, 5–6), of whom 40 (33.9%) patients had died. Forty-two (35.6%) patients were independent (modified Rankin Scale scores, 0–2). Coma (odds ratio, 2.39 [95% CI, 1.03–5.56]) and fixed dilated pupil (odds ratio, 2.22 [95% CI, 0.90–4.92]) were predictors of death or severe disability. Of the survivors, 56 (78.9%) patients and 61 (87.1%) caregivers expressed a positive opinion on surgery. CONCLUSIONS: Two-thirds of patients with severe CVT were alive and more than one-third were independent 1 year after decompressive surgery. Among survivors, surgery was judged as worthwhile by 4 out of 5 patients and caregivers. These results support the recommendation to perform decompressive neurosurgery in patients with CVT with impending brain herniation.

  • Effects of anodal transcranial direct current stimulation over motor cortex on resting-state brain activity in the early subacute stroke phase: A power spectral density analysis
    Tiago Soares Bernardes, Kelly Cristina Sousa Santos, Monalisa Resende Nascimento, César Augusto Noronha e Sousa Filho, Rodrigo Bazan, Janser Moura Pereira, Luciane Aparecida Pascucci Sande de Souza, and Gustavo José Luvizutto

    Elsevier BV

  • The effect of transcranial direct current stimulation combined with task-specific training on spatio-temporal gait parameters and functional mobility in individuals with stroke: a systematic review and meta-analysis
    Jéssica Miranda de Aquino Miranda, Pedro Henrique Sousa de Andrade, Maria Eduarda Salum Aveiro Henrique, Bruno Henrique de Souza Fonseca, Rodrigo Bazan, Luciane Aparecida Pascucci Sande de Souza, and Gustavo José Luvizutto

    Informa UK Limited
    INTRODUCTION Transcranial direct current stimulation (tDCS) has a priming effect on post- stroke motor rehabilitation. OBJECTIVE We verified whether tDCS combined with task-specific training was superior to nonintervention, task-specific training, or simulated intervention in improving spatio-temporal gait parameters and functional mobility in stroke patients. METHODS We searched MEDLINE, EMBASE, CINAHL, Scopus, Cochrane Central, Web of Science, and LILACS for articles published until May 2024, using terms related to stroke, tDCS, and task-specific training. The risk of bias was assessed using the PEDro scale. The Grading of Recommendations, Assessment, Development, and Evaluation methodology was used to classify the certainty of the evidence for each outcome. Meta-analysis was performed using a random-effects model. RESULTS A total of 1,685 studies were identified, of which 18 were included in the qualitative analysis. Seven studies were included in the meta-analysis; all outcomes were classified as "very low quality." Improvements in walking speed only were associated with tDCS combined with task-specific training (mean difference [MD], 0.06; 95% confidence interval [CI]: 0.04, 0.07; p < 0.001; I  = 0%). There were no differences in other spatio-temporal gait parameters or functional mobility. CONCLUSION This systematic review provides low-quality evidence that tDCS, in combination with task-specific training, increases speed in individuals after stroke. Both interventions, tDCS and task-specific training, are inexpensive and easy to implement; therefore, the mean estimate may be considered clinically worthwhile, although the CIs spans both clinically trivial and worthwhile effects. REGISTRATION International Prospective Register of Systematic Reviews (PROSPERO; number CRD42023396021).

  • Palliative Care and the Self-Fulfilling Prophecy in Stroke Patients: is There Anything to Fear? A Retrospective Study of Patients Who Died During Hospitalization in a Quaternary Care Hospital
    Maiara Silva Tramonte, Ana Claudia Pires Carvalho, Gabriela Figueiredo Pucci, Mariana Soares Pinheiro, Ana Elisa Vayego Fornazari, Gustavo Di Lorenzo Villas Boas, Marcos Christiano Lange, Marcos Ferreira Minicucci, Rodrigo Bazan, and Laura Cardia Gomes Lopes

    SAGE Publications
    Background and Purpose Primary palliative care (PC) aims to improve the quality of life for patients with acute ischemic stroke but is often misinterpreted as withdrawal of care. The self-fulfilling prophecy withdrawal bias is feared in this context of PC’s early implementation. This study evaluates stroke patients who died in the hospital to determine the impact of PC evaluation. Methods A retrospective descriptive analysis of patients who died from acute ischemic stroke was conducted. The study included patients aged ≥18 years admitted to the Stroke Unit of a quaternary hospital in Brazil from January 2017 to December 2018. The impact of PC assessment on outcomes was analyzed, with significance set at 5%. Results Among the patients who died during hospitalization as a result of an ischemic stroke (n = 77), 39 (%) were assessed by the palliative care team. There was no difference in the total length of stay or duration of antibiotic therapy. Logistic regression corrected for significant variables from the univariate analysis revealed that PC evaluation was associated with a 31-fold increase in opioid use ( P &lt; 0.001), a nearly 14-fold increase in discharges to the ward, and a threefold reduction in ICU length of stay ( P = 0.011). Conclusion PC team involvement was associated with higher rates of discharge to the floors, inferring more time spent with family and increased opioid use, suggesting better symptom control, without reducing the overall length of stay or duration of antibiotic therapy. This underscores that PC does not equate to withdrawal of care.

  • Articulated ankle-foot orthoses associated with home-based task-specific training improve functional mobility in patients with stroke: a randomized clinical trial
    Gabriela Vieira de Paula, Gustavo José Luvizutto, Luana Aparecida Miranda, Taís Regina da Silva, Lucas Tadeu Carvalho Silva, Fernanda Cristina Winckler, Gabriel Pinheiro Modolo, Cristiane Lara Mendes Chiloff, Silméia Garcia Zanati Bazan, Rafael Dalle Molle da Costa,et al.

    Informa UK Limited
    INTRODUCTION We compared fixed and articulated ankle-foot orthoses (AFOs) in home-based mobility tasks to assess short-term mobility, dynamic balance, quality of life, anxiety/depression, disability level, stroke severity, autonomy, human functioning, and patient satisfaction. METHODS This was a two-arm, parallel-group, randomized controlled trial with concealed allocation, assessor blinding, and a complete case analysis involving patients with chronic stroke. The participants were randomized into two groups: fixed (n = 24) and articulated (n = 23) AFOs. The AFOs were custom-fabricated, and both groups performed four-week home-based mobility tasks five days weekly. Primary outcome measures included changes in balance and mobility assessed using the Tinetti Performance-Oriented Mobility Assessment (POMA), Timed Up and Go (TUG) test, and Functional Ambulation Category (FAC). Secondary outcomes included quality of life, anxiety/depression, disability, stroke severity, autonomy, human functioning, and patient satisfaction. RESULTS In a between-group comparison, after adjusting for age, sex, stroke severity, and thrombolysis, the articulated AFO group showed better performance in the TUG test (p = 0.020; d = 0.93), POMA-Gait (p = 0.001; d = 0.53), POMA-Total (p = 0.048; d = 0.98), and FAC (p = 0.003; d = 1.03) than the fixed AFO group. Moreover, significant difference was noted in human functioning (moving around using equipment)between the groups (p = 0.047; d = 92). CONCLUSION A program involving home-based mobility tasks and articulated AFOs improved functional mobility after stroke.

  • Repetitive peripheral sensory stimulation for motor recovery after stroke: a scoping review
    Gabrielly Fernanda Silva, Lorrane Freitas Campos, Jéssica Mariana de Aquino Miranda, Flávia Guirro Zuliani, Bruno Henrique de Souza Fonseca, Amaro Eduardo Tavares de Araújo, Priscilla Flávia de Melo, Luiz Gustavo Suzuki, Luiz Paulo Aniceto, Rodrigo Bazan,et al.

    Informa UK Limited
    BACKGROUND AND PURPOSE Enhancing afferent information from the paretic limb can improve post-stroke motor recovery. However, uncertainties exist regarding varied sensory peripheral neuromodulation protocols and their specific impacts. This study outlines the use of repetitive peripheral sensory stimulation (RPSS) and repetitive magnetic stimulation (rPMS) in individuals with stroke. METHODS This scoping review was conducted according to the JBI Evidence Synthesis guidelines. We searched studies published until June 2023 on several databases using a three-step analysis and categorization of the studies: pre-analysis, exploration of the material, and data processing. RESULTS We identified 916 studies, 52 of which were included (N = 1,125 participants). Approximately 53.84% of the participants were in the chronic phase, displaying moderate-to-severe functional impairment. Thirty-two studies used RPSS often combining it with task-oriented training, while 20 used rPMS as a standalone intervention. The RPSS primarily targeted the median and ulnar nerves, stimulating for an average of 92.78 min at an intensity that induced paresthesia. RPMS targeted the upper and lower limb paretic muscles, employing a 20 Hz frequency in most studies. The mean stimulation time was 12.74 min, with an intensity of 70% of the maximal stimulator output. Among the 114 variables analyzed in the 52 studies, 88 (77.20%) were in the "s,b" domain, with 26 (22.8%) falling under the "d" domain of the ICF. DISCUSSION AND CONCLUSION Sensory peripheral neuromodulation protocols hold the potential for enhancing post-stroke motor recovery, yet optimal outcomes were obtained when integrated with intensive or task-oriented motor training.

  • Challenges in adapting a stroke unit in a middle-income country: warning about costs and underfunding to achieve the Brazilian Ministry of Health’s benchmark
    Natalia Cristina Ferreira, Gustavo José Luvizutto, Silméia Garcia Zanati Bazan, Luana Aparecida Miranda Bonome, Fernanda Cristina Winckler, Daniel Fabiano Barbosa dos Santos, Cristiane Lara Mendes Chiloff, Gabriel Pinheiro Modolo, Carlos Clayton Macedo de Freitas, Pasqual Barretti,et al.

    Frontiers Media SA
    BackgroundSince the implementation of the stroke care line in Brazil, the relationship (adequacy) of costs spent during hospitalization with the Brazilian Ministry of Health indicators for a stroke unit have not yet been analyzed.AimsThis study aimed to assess the adequacy of a comprehensive stroke center for key performance indicators and analyze the costs involved in hospitalization. We verified the association between stroke severity at admission and care costs during hospitalization.MethodsA retrospective medical chart review of 451 patients was performed using semiautomatic electronic data from a single comprehensive stroke center in Brazil between July 2018 and January 2020. Clinical and resource utilization data were collected, and the mean acute treatment cost per person was calculated. The Kruskal–Wallis test with Dunn’s post-test was used to compare the total costs between stroke types and reperfusion therapies. A robust linear regression test was used to verify the association between stroke severity at hospital admission and the total hospitalization costs. Good adequacy rates were observed for several indicators.ResultsData from 451 patients were analyzed. The stroke unit had good adaptation to key performance indicators, but some critical points needed revision and improvement to adapt to the requirements of the Ministry of Health. The average total cost of the patient’s stay was the USD 2,637.3, with the daily hospitalization, procedure, operating room, and materials/medication costs equating to USD 2,011.1, USD 220.7, USD 234.1, and USD 98.8, respectively. There was a positive association between the total cost and length of hospital stay (p &amp;lt; 0.001).ConclusionThe stroke unit complied with most of the main performance indicators proposed by the Brazilian Ministry of Health. Underfunding of the costs involved in the hospitalization of patients was verified, and high costs were associated with the length of stay, stroke severity, and mechanical thrombectomy.

  • To what extent does frailty mediate the association between age and the outcomes of brain reperfusion following acute ischemic stroke?
    Luana Aparecida Miranda, Gustavo José Luvizutto, Pedro Augusto Cândido Bessornia, Natalia Eduarda Furlan, Fernanda Cristina Winckler, Natalia Cristina Ferreira, Pedro Tadao Hamamoto Filho, Juli Thomaz de Souza, Luis Cuadrado Martin, Silméia Garcia Zanati Bazan,et al.

    Frontiers Media SA
    ObjectiveWe evaluated the extent to which frailty mediated the association between age, poor functional outcomes, and mortality after acute ischemic stroke when patients were treated with brain reperfusion (thrombolytic therapy and/or thrombectomy).Materials and methodsThis retrospective cohort study included patients diagnosed with ischemic stroke who had undergone intravenous cerebral reperfusion therapy and/or mechanical thrombectomy. We created a mediation model by analyzing the direct natural effect of an mRS score &amp;gt; 2 and death on age-mediated frailty according to the Frailty Index.ResultsWe enrolled 292 patients with acute ischemic stroke who underwent brain reperfusion. Their mean age was 67.7 ± 13.1 years. Ninety days after the stroke ictus, 54 (18.5%) participants died, and 83 (28.4%) lived with moderate to severe disability (2 &amp;lt; mRS &amp;lt; 6). In the mediation analysis of the composite outcome of disability (mRS score &amp;gt; 2) or death, frailty accounted for 28% of the total effect of age. The models used to test for the interaction between age and frailty did not show statistically significant interactions for either outcome, and the addition of the interaction did not significantly change the direct or indirect effects, nor did it improve model fit.ConclusionFrailty mediated almost one-third of the effect of age on the composite outcome of disability or death after acute ischemic stroke.

  • Influence of CReatine supplementation on mUScle mass and strength after stroke (ICaRUS Stroke Trial): study protocol for a randomized controlled trial
    Juli Thomaz de Souza, Marcos F. Minicucci, Natália C. Ferreira, Bertha F. Polegato, Marina Politi Okoshi, Gabriel P. Modolo, Bethan E. Phillips, Philip J. Atherton, Kenneth Smith, Daniel Wilkinson,et al.

    Springer Science and Business Media LLC
    Abstract Background Stroke is a leading cause of mortality and disability, and its sequelae are associated with inadequate food intake which can lead to sarcopenia. The aim of this study is to verify the effectiveness of creatine supplementation on functional capacity, strength, and changes in muscle mass during hospitalization for stroke compared to usual care. An exploratory subanalysis will be performed to assess the inflammatory profiles of all participants, in addition to a follow-up 90 days after stroke, to verify functional capacity, muscle strength, mortality, and quality of life. Methods Randomized, double-blind, unicenter, parallel-group trial including individuals with ischemic stroke in the acute phase. The duration of the trial for the individual subject will be approximately 90 days, and each subject will attend a maximum of three visits. Clinical, biochemical, anthropometric, body composition, muscle strength, functional capacity, degree of dependence, and quality of life assessments will be performed. Thirty participants will be divided into two groups: intervention (patients will intake one sachet containing 10g of creatine twice a day) and control (patients will intake one sachet containing 10g of placebo [maltodextrin] twice a day). Both groups will receive supplementation with powdered milk protein serum isolate to achieve the goal of 1.5g of protein/kg of body weight/day and daily physiotherapy according to the current rehabilitation guidelines for patients with stroke. Supplementation will be offered during the 7-day hospitalization. The primary outcomes will be functional capacity, strength, and changes in muscle mass after the intervention as assessed by the Modified Rankin Scale, Timed Up and Go test, handgrip strength, 30-s chair stand test, muscle ultrasonography, electrical bioimpedance, and identification of muscle degradation markers by D3-methylhistidine. Follow-up will be performed 90 days after stroke to verify functional capacity, muscle strength, mortality, and quality of life. Discussion The older population has specific nutrient needs, especially for muscle mass and function maintenance. Considering that stroke is a potentially disabling event that can lead the affected individual to present with numerous sequelae, it is crucial to study the mechanisms of muscle mass loss and understand how adequate supplementation can help these patients to better recover. Trial registration The Brazilian Clinical Trials Registry (ReBEC) RBR-9q7gg4. Registered on 21 January 2019.

  • Sexual dimorphism in the murine model of extraparenchymal neurocysticercosis
    Carlos Alexandre Aguiar Moreira, Luis Henrique Vallesquino Murayama, Tatiane de Camargo Martins, Vinicius Tadeu Oliveira, Diego Generoso, Vania Maria de Vasconcelos Machado, Sabrina Setembre Batah, Alexandre Todorovic Fabro, Rodrigo Bazan, Marco Antônio Zanini,et al.

    Springer Science and Business Media LLC

  • Evolution of Myocardial Hypertrophy Associated With Pregnancy in Hypertensive Women Six Months Postpartum
    Milena Miranda Vasconcelos, Camilla Sousa Ganan, Caroline Ferreira da Silva Mazeto Pupo da Silveira, Karina Nogueira Dias Secco Malagutte, Juliane Rosa Poiati, Hélio Rubens de Carvalho Nunes, Luis Cuadrado Martin, Rodrigo Bazan, Vera Therezinha Medeiros Borges, and Silméia Garcia Zanati Bazan

    Elsevier BV

  • The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
    Lu Ma, Xin Hu, Lili Song, Xiaoying Chen, Menglu Ouyang, Laurent Billot, Qiang Li, Alejandra Malavera, Xi Li, Paula Muñoz-Venturelli,et al.

    Elsevier BV

  • Effect of a Physical Exercise Program on the Inflammatory Response, Cardiac Functions, Functional Capacity, and Quality of Life in Patients with Sickle Cell Disease
    Daniele Andreza Antonelli Rossi, Jonas Alves De Araujo Junior, Gustavo José Luvizutto, Rodrigo Bazan, Péricles Sidnei Salmazo, Gabriel Pinheiro Modolo, João Carlos Hueb, Hélio Rubens de Carvalho Nunes, Newton Key Hokama, Marcos Ferreira Minicucci,et al.

    MDPI AG
    Introduction: The beneficial effects of physical exercise on functional capacity and inflammatory response are well-known in cardiovascular diseases; however, studies on sickle cell disease (SCD) are limited. It was hypothesized that physical exercise may exert a favorable effect on the inflammatory response of SCD patients, contributing to an improved quality of life. This study aimed to evaluate the effect of a regular physical exercise program on the anti-inflammatory responses in SCD patients. Methods: A non-randomized clinical trial was conducted in adult SCD patients. The patients were divided into two groups: 1—Exercise Group, which received a physical exercise program three times a week for 8 weeks, and; 2—Control Group, with routine physical activities. All patients underwent the following procedures initially and after eight weeks of protocol: clinical evaluation, physical evaluation, laboratory evaluation, quality of life evaluation, and echocardiographic evaluation. Statistical analysis: Comparisons between groups were made using Student’s t-test, Mann–Whitney test, chi-square test, or Fisher’s exact test. Spearman’s correlation coefficient was calculated. The significance level was set at p &lt; 0.05. Results: There was no significant difference in inflammatory response between the Control and Exercise Groups. The Exercise Group showed an improvement in peak VO2 values (p &lt; 0.001), an increase in the distance walked (p &lt; 0.001), an improvement in the limitation domain due to the physical aspects of the 36-Item Short Form Health Survey (SF-36) quality of life questionnaire (p = 0.022), and an increase in physical activity related to leisure (p &lt; 0.001) and walking (p = 0.024) in the International Physical Activity Questionnaire (IPAQ). There was a negative correlation between IL-6 values and distance walked on the treadmill (correlation coefficient −0.444, p = 0.020) and the estimated peak VO2 values (correlation coefficient −0.480; p = 0.013) in SCD patients in both groups. Conclusions: The aerobic exercise program did not change the inflammatory response profile of SCD patients, nor did it show unfavorable effects on the parameters evaluated, and patients with lower functional capacity were those with the highest levels of IL-6.

RECENT SCHOLAR PUBLICATIONS

  • Abstract TP217: Prognostic Factors in Craniocervical Artery Dissection: A Latin American Cohort Study.
    D Reges, E Navarro Borba Adissy, R Lopes, M Trombin Marques, ...
    Stroke 56 (Suppl_1), ATP217-ATP217 2025

  • Long-term effect of non-invasive brain stimulation on hemispatial neglect, functional outcomes, and mortality after stroke: ELETRON trial extend
    LA Miranda, FC Winckler, TR da Silva, HR de Carvalho Nunes, ...
    Clinical Neurology and Neurosurgery 249, 108705 2025

  • Effects of anodal transcranial direct current stimulation on intracranial compliance in the subacute phase of stroke
    MR Nascimento, TS Bernardes, KCS Santos, GF Silva, R Bazan, ...
    Clinical Neurology and Neurosurgery 247, 108597 2024

  • ID213 Anlise de microcusteio do tratamento do Acidente Vascular Cerebral Isqumico na perspectiva de um hospital pblico: EIXO 1: SUSTENTABILIDADE NOS SISTEMAS DE SADE
    VSN Nogueira, JTC de Almeida, R Bazan, SN Silva, LF Silva, JM Rugolo, ...
    JORNAL DE ASSISTNCIA FARMACUTICA E FARMACOECONOMIA 9 (s. 1) 2024

  • Influence of CReatine Supplementation on mUScle Mass and Strength After Stroke (ICaRUS Stroke Trial): A Randomized Controlled Trial
    JT Souza, MF Minicucci, NC Ferreira, BF Polegato, MP Okoshi, ...
    Nutrients 16 (23), 4148 2024

  • Prevalence of motoric cognitive risk syndrome among older adults in Brazil and evaluation of effect modification by race
    JP Martins, FB Fukushima, LN Benatti, R Bazan, KDSC Silva, EIO Vidal
    Journal of Alzheimer’s Disease, 13872877241300296 2024

  • Caregiver burden, hopelessness, and anxiety: Association between sociodemographic and clinical profiles of patients with stroke
    LHV Murayama, PT Hamamoto Filho, FC Winckler, HAA Meirelles, ...
    Journal of Stroke and Cerebrovascular Diseases 33 (11), 107905 2024

  • Custo Direto do Tratamento do Acidente Vascular Cerebral Isqumico na Perspectiva de um Hospital Pblico Tercirio (Direct Cost of Treating Ischemic Stroke From the Perspective
    JTC de Almeida, R Bazan, SN Silva, LF Silva, JM Rugolo, MAP de Sordi, ...
    Value in Health Regional Issues 44, 101019 2024

  • The effect of transcranial direct current stimulation combined with task-specific training on spatio-temporal gait parameters and functional mobility in individuals with stroke
    J Miranda de Aquino Miranda, PH Sousa de Andrade, MESA Henrique, ...
    Topics in Stroke Rehabilitation, 1-20 2024

  • Repetitive peripheral sensory stimulation for motor recovery after stroke: a scoping review
    G Fernanda Silva, LF Campos, JM de Aquino Miranda, F Guirro Zuliani, ...
    Topics in Stroke Rehabilitation 31 (7), 723-737 2024

  • PROPOSAL FOR A DECISION-MAKING PROTOCOL FOR DOSES EXERCISE MONITORING BASED ON HOME TASK-ORIENTED TRAINING IN THE SUBACUTE PHASE OF STROKE
    N Machado, J Cagliari, MT Lenza, P Andrade, L Miranda, R Bazan, ...
    INTERNATIONAL JOURNAL OF STROKE 19 (2), 322-322 2024

  • CRANIOCERVICAL ARTERIAL DISSECTION EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS IN A MULTI ETHNIC SOUTH AMERICAN POPULATION
    DS Reges, R Pinto, E Navarro, V Colares, F Migliolli, F Machado, ...
    INTERNATIONAL JOURNAL OF STROKE 19 (2), 260-261 2024

  • THROMBOLYSIS AND THROMBECTOMY IN CERVICAL ARTERY DISSECTION THE EXPERIENCE OF FOUR CENTERS IN LATIN AMERICAN
    DS Reges, E Navarro, R Pinto, V Colares, M Marques, F Migliolli, ...
    INTERNATIONAL JOURNAL OF STROKE 19 (2), 261-261 2024

  • REFERRALS TO OUTPATIENT STROKE REHABILITATION IN BRAZIL: INSIGHTS FROM THE AREA STUDY
    R Cacho, A Conforto, C Moro, S Da Guarda, E Pinto, G Luvizutto, L Souza, ...
    INTERNATIONAL JOURNAL OF STROKE 19 (2), 303-303 2024

  • LONG-TERM EFFECT OF NON-INVASIVE BRAIN STIMULATION ON HEMISPATIAL NEGLECT, FUNCTIONAL OUTCOMES AND MORTALITY AFTER STROKE: ELETRON TRIAL EXTEND
    L Miranda, F Winckler, T Da Silva, HR Nunes, G Modolo, N Ferreira, ...
    INTERNATIONAL JOURNAL OF STROKE 19 (2), 321-321 2024

  • EFFECT OF TRANSCRANIAL MAGNETIC STIMULATION BY THETA BURST MODALITY AND TRANSCRANIAL DIRECT CURRENT STIMULATION IN UNILATERAL SPATIAL NEGLECT AFTER STROKE: TITAN TRIAL PROTOCOL
    L Miranda, F Winckler, T Ricci, G De Paula, N Ferreira, M Nackachima, ...
    INTERNATIONAL JOURNAL OF STROKE 19 (2), 321-321 2024

  • Palliative Care and the Self-Fulfilling Prophecy in Stroke Patients: is There Anything to Fear? A Retrospective Study of Patients Who Died During Hospitalization in a
    MS Tramonte, ACP Carvalho, GF Pucci, MS Pinheiro, AEV Fornazari, ...
    American Journal of Hospice and Palliative Medicine, 10499091241286059 2024

  • Left Atrial Volume versus Coronary Artery Calcium Score in Patients on Peritoneal Dialysis: An Observational Study
    FM Reis, EB Ferrari, NSC Reis, FL Costa, PN Morimoto, ADCV Maurcio, ...
    Journal of Clinical Medicine 13 (18), 5539 2024

  • Articulated ankle-foot orthoses associated with home-based task-specific training improve functional mobility in patients with stroke: a randomized clinical trial
    GV Paula, GJ Luvizutto, LA Miranda, T Regina da Silva, LTC Silva, ...
    Topics in Stroke Rehabilitation, 1-14 2024

  • Decompressive Craniectomy in Patients with Malignant Stroke with Additional Vascular Territory
    RP Sampaio, MO Fogaroli, FP Botta, GP Mdolo, GJ Luvizutto, LE Betting, ...
    World Neurosurgery 189, e948-e952 2024

MOST CITED SCHOLAR PUBLICATIONS

  • Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

    The new england journal o f medicine 374 (24), 2313-2323 2016
    Citations: 549

  • Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
    SC Johnston, P Amarenco, GW Albers
    New England Journal of Medicine 375 (1), 35-43 2016
    Citations: 538

  • Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint
    CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ...
    The Lancet 393 (10174), 877-888 2019
    Citations: 270

  • Enzyme replacement therapy for Anderson‐Fabry disease
    R El Dib, H Gomaa, RP Carvalho, SE Camargo, R Bazan, P Barretti, ...
    Cochrane Database of Systematic Reviews 2016
    Citations: 259

  • Thrombectomy for stroke in the public health care system of Brazil
    SO Martins, F Mont’Alverne, LC Rebello, DG Abud, GS Silva, FO Lima, ...
    New England Journal of Medicine 382 (24), 2316-2326 2020
    Citations: 227

  • Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke
    HI Coordinators
    The New England Journal of Medicine 25 (376), 2437-2447 2017
    Citations: 218

  • The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
    L Ma, X Hu, L Song, X Chen, M Ouyang, L Billot, Q Li, A Malavera, X Li, ...
    The Lancet 402 (10395), 27-40 2023
    Citations: 215

  • Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
    SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ...
    The Lancet Neurology 17 (12), 1053-1060 2018
    Citations: 197

  • Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia.
    MF Milanezi, FP Saggioro, SG Zanati, R Bazan, FC Schmitt
    Journal of Clinical Pathology 51 (3), 204-206 1998
    Citations: 113

  • Dysphagia and tube feeding after stroke are associated with poorer functional and mortality outcomes
    JT Souza, PW Ribeiro, SAR de Paiva, SE Tanni, MF Minicucci, ...
    Clinical Nutrition 39 (9), 2786-2792 2020
    Citations: 68

  • Relationship between dysphagia, national institutes of health stroke scale score, and predictors of pneumonia after ischemic stroke
    PW Ribeiro, PC Cola, AR Gatto, RG da Silva, GJ Luvizutto, GP Braga, ...
    Journal of Stroke and Cerebrovascular Diseases 24 (9), 2088-2094 2015
    Citations: 56

  • Brazilian guidelines for endovascular treatment of patients with acute ischemic stroke
    OM Pontes-Neto, P Cougo, SCO Martins, DG Abud, RG Nogueira, ...
    Arquivos de neuro-psiquiatria 75 (1), 50-56 2017
    Citations: 53

  • Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials
    VP da Rovare, GPA Magalhes, GDA Jardini, ML Beraldo, MO Gameiro, ...
    Complementary therapies in medicine 34, 170-185 2017
    Citations: 49

  • Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial
    H Chabriat, CL Bassetti, U Marx, ML Audoli-Inthavong, A Sors, E Lambert, ...
    The Lancet Neurology 19 (3), 226-233 2020
    Citations: 44

  • Influence of intradialytic aerobic training in cerebral blood flow and cognitive function in patients with chronic kidney disease: a pilot randomized controlled trial
    F Stringuetta Belik, VR Oliveira e Silva, GP Braga, R Bazan, B Perez Vogt, ...
    Nephron 140 (1), 9-17 2018
    Citations: 43

  • Noninvasive brain stimulations for unilateral spatial neglect after stroke: A systematic review and meta‐analysis of randomized and nonrandomized controlled trials
    FT Kashiwagi, R El Dib, H Gomaa, N Gawish, EA Suzumura, TR da Silva, ...
    Neural plasticity 2018 (1), 1638763 2018
    Citations: 43

  • Effects of virtual reality therapy on upper limb function after stroke and the role of neuroimaging as a predictor of a better response
    MG Gonalves, MFL Piva, CLS Marques, RDM da Costa, R Bazan, ...
    Arquivos de Neuro-psiquiatria 76 (10), 654-662 2018
    Citations: 40

  • Clinical symptoms, imaging features and cyst distribution in the cerebrospinal fluid compartments in patients with extraparenchymal neurocysticercosis
    R Bazan, PT Hamamoto Filho, GJ Luvizutto, HRC Nunes, NS Odashima, ...
    PLoS neglected tropical diseases 10 (11), e0005115 2016
    Citations: 40

  • Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
    SB Coutts, S Ankolekar, R Appireddy, JF Arenillas, Z Assis, P Bailey, ...
    The Lancet 403 (10444), 2597-2605 2024
    Citations: 36

  • Effect of a quality improvement intervention on adherence to therapies for patients with acute ischemic stroke and transient ischemic attack: a cluster randomized clinical trial
    MJ Machline-Carrion, EV Santucci, LP Damiani, MC Bahit, G Mlaga, ...
    JAMA neurology 76 (8), 932-941 2019
    Citations: 36